Citation Impact
Citing Papers
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
2009 Standout
Cancer immunotherapies targeting the PD-1 signaling pathway
2017 StandoutNobel
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
2020
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Osimertinib: First Global Approval
2016
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Pathogenesis and clinical features of psoriasis
2007 Standout
Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies
2008
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Dimethylfumarate Specifically Inhibits the Mitogen and Stress-Activated Kinases 1 and 2 (MSK1/2): Possible Role for its Anti-Psoriatic Effect
2007
Macrophages in immunoregulation and therapeutics
2023 Standout
Psychological stress suppresses innate IFN-γ production via glucocorticoid receptor activation: Reversal by the anxiolytic chlordiazepoxide
2009
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
2011 Standout
Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-l-cysteine—Preparation of S-substituted thiosuccinic acid esters
2006
Psoriasis
2021 Standout
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Cytokine Secretion Pattern in Treatment of Lymphocytes of Multiple Sclerosis Patients with Fumaric Acid Esters
2011
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Psoriasis
2015 Standout
Fiber-optic particle plasmon resonance sensor for detection of interleukin-1β in synovial fluids
2010
Immunopathology of multiple sclerosis
2015 Standout
Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate
2017
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
2013
Innate and adaptive immunity and the pathophysiology of psoriasis
2006
EGFR tyrosine kinase inhibitorsversuschemotherapy inEGFRwild-type pre-treated advanced nonsmall cell lung cancer in daily practice
2017
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
2006
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
2015
CpG-containing immunostimulatory DNA sequences elicit TNF-α–dependent toxicity in rodents but not in humans
2009
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
2006
Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients.
2009
Psoriasis Pathogenesis and Treatment
2019 Standout
Investigation of binding and activity of perfluoroalkyl substances to the human peroxisome proliferator-activated receptor β/δ
2019
Targeting ALK: Precision Medicine Takes on Drug Resistance
2017
Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis
2015
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
2011
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
2015
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Regulated genes in psoriatic skin during treatment with fumaric acid esters
2014
Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
2015
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
2018
Consensus Guidelines for the Management of Plaque Psoriasis
2012
Works of Andrew Walding being referenced
Human peripheral blood mononuclear cells express GABAA receptor subunits
2005
Monomethylfumarate affects polarization of monocyte‐derived dendritic cells resulting in down‐regulated Th1 lymphocyte responses
2004
Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1β-driven model of joint pathology
2008
Activation of E-prostanoid4and E-prostanoid2receptors inhibits TNF-α release from human alveolar macrophages
2007
Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists
2010
1551 Patient experience of symptoms and side effects when treated with AZD9291 for advanced non-small-cell lung cancer: A qualitative interview sub-study
2015
3030 Patient-reported symptom response and impact of treatment with AZD9291 for advanced non-small-cell lung cancer
2015
136O: Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial
2016